Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

CJC-1295: Bloodwork Guide

Recommended lab tests and biomarkers to monitor before, during, and after CJC-1295 therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.

Back to CJC-1295 overview

Before Starting (3 tests)

Biomarker Expected Effect Retest
Fasting Glucose → normalizes Once (baseline)
Cortisol → normalizes Once (baseline)
IGF-1 → normalizes Once (baseline)

During Treatment (3 tests)

Biomarker Expected Effect Retest
IGF-1 ↑ increases Every 8 weeks
GH ↑ increases Every 4 weeks
Prolactin → normalizes Every 8 weeks